IMP 243

• UNSPSC Description:

  IMP 243 is a symmetric di-HSG (histamine-succinyl-glycine) bivalent hapten containing a Tscg-Cys ligand and two HSG groups. IMP 243 can be radiolabeled with 99mTc-pertechnetate. IMP 243 can be conjugated to other peptides to design bispecific antibodies (bsMAbs) for cancer research[1].

• Target Antigen:

  Biochemical Assay Reagents

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/imp-243.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(CCC(NCC(NCCCC[C@@H](C(N[C@@H](C(N[C@H](C(N[C@H](C(N)=O)CCCCNC([C@H](CS)NC(/C=N\NC(N)=S)=O)=O)=O)CCCCNC(CNC(CCC(NCCC1=CNC=N1)=O)=O)=O)=O)CC2=CC=C(O)C=C2)=O)NC(C)=O)=O)=O)NCCC3=CNC=N3

• Molecular Weight:

  1339.55

• References & Citations:

  [1]Sharkey RM, et al. A universal pretargeting system for cancer detection and therapy using bispecific antibody. Cancer Res. 2003 Jan 15;63(2):354-63.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  391267-29-1